Tuberous Sclerosis 2: Clinical Trials

1 trial for Tuberous Sclerosis 2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Tuberous Sclerosis 2: new trials by email Literature Review of Tuberous Sclerosis 2 trials Research Report on Tuberous Sclerosis 2

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
nab-sirolimus - Tumor, Tumor, Solid
Phase 2CompletedAadi Bioscience, Inc.1282022-03-102026-10-28

Narrower conditions

Hereditary Sensory and Autonomic Neuropathies (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms (1)  ·  Tuberous Sclerosis 1 (1)

Broader conditions

Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Neoplastic Processes (1)  ·  Nervous System Diseases (1)  ·  Nervous System Malformations (1)  ·  Neurodegenerative Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Peripheral Nervous System Diseases (1)  ·  Polyneuropathies (1)

Sponsors

Aadi Bioscience, Inc. (1)

Countries

Puerto Rico (1)  ·  South Korea (1)  ·  United States (1)